跳转至内容
Merck
CN

SML0797

氟班色林

≥98% (HPLC)

别名:

1,3-二氢-1-[2-[4-[3-(三氟甲基)苯基]-1-哌嗪基]乙基]-2H-苯并咪唑-2-酮, BIMT 17, BIMT 17BS

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C20H21F3N4O
化学文摘社编号:
分子量:
390.40
UNSPSC Code:
12352200
NACRES:
NA.77
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

SMILES string

FC(F)(F)c1ccc(cc1)N2CCN(CC2)CC[n]3c4c([nH][c]3=O)cccc4

InChI

1S/C20H21F3N4O/c21-20(22,23)15-5-7-16(8-6-15)26-12-9-25(10-13-26)11-14-27-18-4-2-1-3-17(18)24-19(27)28/h1-8H,9-14H2,(H,24,28)

InChI key

CCIZQGRSEAHATK-UHFFFAOYSA-N

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 10 mg/mL, clear

storage temp.

2-8°C

Quality Level

Biochem/physiol Actions

氟班色林是 5-HT1A 受体激动剂和 5-HT2A 受体拮抗剂。
氟班色林是 5-HT1A 受体激动剂和 5-HT2A 受体拮抗剂。氟班色林对人 5-HT1A受体 (Ki = 1 nm) 具有高亲和力,对 5-HT2A (Ki = 49 nm) 和 D4 (Ki = 4–24 nm) 受体亲和力较低,对多种其他神经递质受体和离子通道的亲和力可忽略不计。氟班色林被用作女性绝经前性欲减退 (HSDD) 的一种新型非激素治疗方法。氟班色林。最近,在帕金森氏病模型中发现氟班色林可减轻 L-DOPA 引起的运动障碍。

Features and Benefits

这种化合物是神经科学研究的特色产品。点击此处发现更多特色神经科学产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。

pictograms

Skull and crossbones

signalword

Danger

Hazard Classifications

Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

John Thorp et al.
The journal of sexual medicine, 9(3), 793-804 (2012-01-14)
Hypoactive Sexual Desire Disorder (HSDD) is characterized by low sexual desire that causes marked distress or interpersonal difficulty. To assess the efficacy and tolerability of flibanserin, a postsynaptic 5-HT1A agonist/5-HT2A antagonist, in the treatment of premenopausal women with HSDD. North
Dysfunctional women remain unsexed.
Michael G Wyllie
BJU international, 106(3), 431-432 (2010-07-27)
Drug for low sexual desire carries significant harms, FDA advisers find.
Ray Moynihan
BMJ (Clinical research ed.), 341, c3339-c3339 (2010-07-09)
Leonard R Derogatis et al.
The journal of sexual medicine, 9(4), 1074-1085 (2012-01-18)
Hypoactive sexual desire disorder (HSDD) is the most common form of female sexual dysfunction and is characterized by low sexual desire that causes distress. The aim of this study was to assess the efficacy and safety of flibanserin, a postsynaptic
Sidney Kennedy
The journal of sexual medicine, 7(10), 3449-3459 (2010-07-22)
Flibanserin, a novel 5-HT(1A) agonist and 5-HT(2A) antagonist, has the potential to treat sexual dysfunction. Provide historical perspective on the rationale for development of flibanserin to treat sexual dysfunction, based on post hoc analyses of data. The Arizona Sexual Experiences

商品

DISCOVER Bioactive Small Molecules for Neuroscience

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持